You can buy or sell Opthea and other stocks, options, and ETFs commission-free!
Opthea Limited American Depositary Shares, also called Opthea, is a clinical stage biopharmaceutical company that engages in the development of biological therapeutics for the treatment of progressive retinal diseases. It targets to treat neovascular age-related macular degeneration (wet AMD) and diabetic macular edema, which causes visual impairment among elderly and diabetic patients.
South Yarra, Victoria (VIC)
52 Week High
52 Week Low